|
Volumn 9, Issue 1, 2015, Pages
|
A Changing Model for Developing Health Products for Poverty-Related Infectious Diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBENDAZOLE;
AMPHOTERICIN B;
ARTEMETHER;
ARTESUNATE PLUS MEFLOQUINE;
CHLOROQUINE;
EFLORNITHINE;
FOLIC ACID ANTAGONIST;
HALOFANTRINE;
IVERMECTIN;
MEFLOQUINE;
NEW DRUG;
NIFURTIMOX;
PAROMOMYCIN;
PENTAMIDINE;
PRAZIQUANTEL;
PYRAZINAMIDE;
RIFABUTIN;
RIFAPENTINE;
AFRICAN TRYPANOSOMIASIS;
ARTICLE;
CLINICAL TRIAL (TOPIC);
DISEASE ELIMINATION;
DRUG DESIGN;
DRUG INDUSTRY;
HEALTH PROGRAM;
HEALTH SERVICE;
HUMAN;
INFECTION;
INFECTION CONTROL;
LEPROSY;
MALARIA;
MEDICAL RESEARCH;
NEMATODIASIS;
NONHUMAN;
ONCHOCERCIASIS;
POVERTY;
PUBLIC HEALTH SERVICE;
PUBLIC-PRIVATE PARTNERSHIP;
SCHISTOSOMIASIS;
TROPICAL DISEASE;
TUBERCULOSIS;
VISCERAL LEISHMANIASIS;
|
EID: 84922256404
PISSN: 19352727
EISSN: 19352735
Source Type: Journal
DOI: 10.1371/journal.pntd.0003379 Document Type: Article |
Times cited : (12)
|
References (8)
|